Ipsen raises its targets after a 24.5% increase in Q2 revenue
Ipsen reports a 24.5% increase in its second-quarter revenue.
Published 6sem1 sourceNotableupdated 1sem
Lire en français
≈ 16s
The fact
The pharmaceutical group raises its annual targets for 2026.
This performance is driven by the momentum of its key products.
Click the link to read an article on the topic:
Why it matters
La forte croissance d'Ipsen et la révision de ses objectifs illustrent la résilience du secteur pharmaceutique et son attractivité pour les investisseurs.